Close Menu

The Scan

In Science this week: updated reference genome assembly for the rhesus macaque, and more.

Reuters reports the World Health Organization is to send a team of investigators to Wuhan, China early next year.

According to Retraction Watch, a research technician at Washington State University was caught fabricating gene sequencing data.

And After Death

A small study suggests SARS-CoV-2 lingers after people have died of COVID-19, according to the Washington Post.

In Nature this week: computational tool for the hybrid de novo assembly of human genomes, and more.

Two former political appointees at the US Centers for Disease Control and Prevention describe the sidelining of the agency in the New York Times.

Right at Home

The US Food and Drug Administration has authorized an at-home, over-the-counter test for SARS-CoV-2 from Ellume.

Science reports that individuals with Down syndrome are at increased risk of dying from COVID-19, leading to calls for individuals with Down syndrome to be prioritized for vaccination.

In Genome Research this week: approach to predict gene expression from single-cell DNA methylation profiles, oral microbiome of children with cavities, and more.

Support for a Second

A Food and Drug Administration briefing document supports the authorization of Moderna's SARS-CoV-2 vaccine, according to NPR.

Modified Pig Approved

CNN reports that the Food and Drug Administration has approved a genetically modified pig.

New Change Reported

Reuters reports a new SARS-CoV-2 gene variant has been identified in the UK that could be tied to increased spread.

In PNAS this week: variants in Bloom syndrome-related gene increase mesothelioma risk, Streptococcus host transcriptome atlas, and more.

The Food and Drug Administration granted an Emergency Use Authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the New York Times reports.

Many Missed

A new report indicates that lateral-flow testing implemented in the UK may miss a number of SARS-CoV-2 infections, according to the Financial Times.

New Picks

New names for the National Board for Education Sciences draw criticism, Science reports.

In PLOS this week: investigation of pleiotropic effects using GWAS data, transcriptomic study of mosquitoes that spread Rift Valley fever, and more.

Panel Gives Its OK

An advisory panel to the US Food and Drug Administration voted for authorizing Pfizer and BioNTech's SARS-CoV-2 vaccine, the Wall Street Journal reports. 

Early trial data of a Sanofi and GlaxoSmithKline SARS-CoV-2 vaccine indicates an insufficient immune response among older participants, according to Reuters.

Science reports that Tasmanian devils are passing devil facial tumor disease on to a smaller number of other devils.

In Science this week: CRISPR and expression-reported sequencing approach to trace genetic interactions, sample preparation platform for single-cell sequencing, and more.

Quick Viral Tracing

Australian researchers say a nanopore sequencing strategy could quickly trace the source of a SARS-CoV-2 infection, according to Reuters.

The Chronicle of Higher Education reports that faculty are concerned that pandemic-induced budget cuts will affect the university ecosystem.

In Both

A gene therapy for Leber hereditary optic neuropathy given to one eye affected vision of the other, according to New Scientist.

In Nature this week: donkey genome gives insight into domestication, workflow for reference-free assembly of fully phased diploid human genomes, and more.


A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.